Atlas Trials

Biocon Biologics UK PLC

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Biocon Biologics UK PLC

RecordFirmDate
Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma (NCT07581509)Biocon Biologics UK PLC2026-08-01
Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma (NCT07476326)Biocon Biologics UK PLC2026-08-01
A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers (NCT07299955)Biocon Biologics UK PLC2026-02-28

Track Biocon Biologics UK PLC automatically

Every clearance here is in the API, with alerts when new ones post.